18F-Fluciclovine PET/CT用于中高危原发性前列腺癌术前分期
本研究纳入68例中高危前列腺癌患者,在机器人根治性前列腺切除术前行18F-Fluciclovine PET/CT,57例完成方案,31例病理证实淋巴结转移。PET/CT检测淋巴结转移的敏感性和特异性分别为每患者55.3%和84.8%,每区域54.8%和96.4%,敏感性显著高于常规影像,且特异性相似。
要点
- 18F-Fluciclovine PET/CT较常规影像显著提高淋巴结转移检出敏感性。
- 特异性高,有助于指导淋巴结清扫和治疗决策。
- 检测阳性与转移灶大小及总转移负荷相关。
核心结论
- 18F-Fluciclovine PET/CT可检测常规影像未发现的隐匿转移,高特异性有助于指导治疗决策和淋巴结清扫。
研究设计与样本
- 前瞻性研究纳入68例不良中危至极高危前列腺癌患者,常规影像无系统性疾病,行机器人根治性前列腺切除加扩大盆腔淋巴结清扫。
主要发现
- 57例完成方案,31例组织学证实淋巴结转移。
- 每患者敏感性55.3%、特异性84.8%;每区域敏感性54.8%、特异性96.4%。
- 较常规影像,每患者敏感性55.3% vs 33.3%(p<0.01),每区域54.8% vs 19.4%(p<0.01),多检出7例患者和22个区域,特异性相似。
- 4例额外检出远处疾病或其他癌症而未手术。
- 转移检出与淋巴结内转移灶大小和总体转移负荷相关。
临床怎么用
- 对于中高危前列腺癌患者,术前18F-Fluciclovine PET/CT可提高隐匿转移的检出,高特异性支持用于指导淋巴结清扫和治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Accurate preoperative staging of prostate cancer is essential for treatment planning. Conventional imaging is limited in detection of metastases. Our primary aim was to determine if [18F]fluciclovine positron emission tomography/computerized tomography is an early indicator of subclinical metastasis among patients with high risk prostate cancer. MATERIALS AND METHODS: A total of 68 patients with unfavorable intermediate to very high risk prostate cancer without systemic disease on conventional imaging were recruited before robotic radical prostatectomy with extended pelvic lymph node dissection. Diagnostic performance of [18F]fluciclovine positron emission tomography/computerized tomography and conventional imaging for detection of metastatic disease, and correlation of positivity to node and metastatic deposit size were determined. RESULTS: Overall 57 of 68 patients completed the protocol, of whom 31 had nodal metastasis on histology. [18F]Fluciclovine positron emission tomography/computerized tomography sensitivity and specificity in detecting nodal metastasis was 55.3% and 84.8% per patient, and 54.8% and 96.4% per region (right and left pelvis, presacral and nonregional), respectively. Compared with conventional imaging [18F]Fluciclovine positron emission tomography/computerized tomography had significantly higher sensitivity on patient based (55.3% vs 33.3%, p <0.01) and region based (54.8% vs 19.4%, p <0.01) analysis, detecting metastasis in 7 more patients and 22 more regions, with similar high specificity. Four additional patients had distant disease or other cancer detected on [18F] fluciclovine positron emission tomography/computerized tomography which precluded surgery. Detection of metastasis was related to size of metastatic deposits within lymph nodes and overall metastatic burden. CONCLUSIONS: [18F]Fluciclovine positron emission tomography/computerized tomography detects occult metastases not identified on conventional imaging and may help guide treatment decisions and lymph node dissection due to high specificity for metastatic disease.
引用
- Alemozaffar M, Akintayo AA, Abiodun-Ojo OA, et al. [18F]Fluciclovine Positron Emission Tomography/Computerized Tomography for Preoperative Staging in Patients with Intermediate to High Risk Primary Prostate Cancer. J Urol. 2020. PMID: 32347780. doi:10.1097/JU.0000000000001095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。